Net Income Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Beijing Science Sun Pharmaceutical Co., Ltd.'s latest annual net income in 2023 was 102.91 Million CNY , down -49.73% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd.'s latest quarterly net income in 2024 Q3 was 6.95 Million CNY , down -91.87% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported an annual net income of 204.73 Million CNY in 2022, down -49.11% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported an annual net income of 402.27 Million CNY in 2021, up 159.69% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a quarterly net income of 85.46 Million CNY for 2024 Q2, up 144.84% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a quarterly net income of -190.61 Million CNY for 2024 Q1, down -103.63% from previous quarter.

Annual Net Income Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Net Income	Net Income Growth
2023	102.91 Million CNY	-49.73%
2022	204.73 Million CNY	-49.11%
2021	402.27 Million CNY	159.69%
2020	154.9 Million CNY	4.21%
2019	148.63 Million CNY	-47.5%
2018	283.1 Million CNY	0.53%
2017	281.6 Million CNY	8.98%
2016	258.4 Million CNY	23.48%
2015	209.27 Million CNY	3.31%
2014	202.57 Million CNY	25.99%
2013	160.78 Million CNY	21.29%
2012	132.56 Million CNY	56.59%
2011	84.65 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q3	6.95 Million CNY	-91.87%
2024 Q2	85.46 Million CNY	144.84%
2024 Q1	-190.61 Million CNY	-103.63%
2023 Q3	-55.13 Million CNY	-121.98%
2023 Q4	-93.6 Million CNY	-69.77%
2023 FY	102.91 Million CNY	-49.73%
2023 Q1	823.93 Thousand CNY	101.72%
2023 Q2	250.83 Million CNY	30344.03%
2022 FY	204.73 Million CNY	-49.11%
2022 Q2	127.63 Million CNY	19.79%
2022 Q1	106.54 Million CNY	-59.73%
2022 Q4	-47.88 Million CNY	-359.65%
2022 Q3	18.44 Million CNY	-85.55%
2021 Q2	42.92 Million CNY	1.21%
2021 Q4	264.55 Million CNY	405.08%
2021 Q1	42.4 Million CNY	64.67%
2021 FY	402.27 Million CNY	159.69%
2021 Q3	52.37 Million CNY	22.03%
2020 Q1	25.44 Million CNY	16.06%
2020 FY	154.9 Million CNY	4.21%
2020 Q4	25.75 Million CNY	-41.82%
2020 Q3	44.26 Million CNY	-25.53%
2020 Q2	59.44 Million CNY	133.62%
2019 FY	148.63 Million CNY	-47.5%
2019 Q4	21.92 Million CNY	-34.29%
2019 Q3	33.36 Million CNY	-31.31%
2019 Q2	48.57 Million CNY	8.46%
2019 Q1	44.78 Million CNY	-38.6%
2018 FY	283.1 Million CNY	0.53%
2018 Q4	72.94 Million CNY	-6.92%
2018 Q3	78.36 Million CNY	8.93%
2018 Q2	71.93 Million CNY	20.17%
2018 Q1	59.86 Million CNY	-26.8%
2017 Q1	45.29 Million CNY	-20.48%
2017 FY	281.6 Million CNY	8.98%
2017 Q3	94.51 Million CNY	57.48%
2017 Q4	81.78 Million CNY	-13.47%
2017 Q2	60.01 Million CNY	32.51%
2016 Q3	69.64 Million CNY	-4.54%
2016 Q2	72.95 Million CNY	23.96%
2016 Q1	58.85 Million CNY	10.4%
2016 FY	258.4 Million CNY	23.48%
2016 Q4	56.95 Million CNY	-18.22%
2015 Q2	59.45 Million CNY	29.41%
2015 FY	209.27 Million CNY	3.31%
2015 Q4	53.31 Million CNY	5.42%
2015 Q3	50.56 Million CNY	-14.94%
2015 Q1	45.94 Million CNY	-4.76%
2014 Q1	43.1 Million CNY	0.0%
2014 Q2	56.38 Million CNY	30.8%
2014 Q4	48.23 Million CNY	-12.04%
2014 FY	202.57 Million CNY	25.99%
2014 Q3	54.84 Million CNY	-2.73%
2013 FY	160.78 Million CNY	21.29%
2012 FY	132.56 Million CNY	56.59%
2011 FY	84.65 Million CNY	0.0%

Peer Net Income Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.

Name	Net Income	Net Income Difference
Shenzhen Kangtai Biological Products Co., Ltd.	861.3 Million CNY	88.051%
PharmaBlock Sciences (Nanjing), Inc.	197.36 Million CNY	47.853%
Shandong Shanda Wit Science and Technology Co., Ltd.	585.26 Million CNY	82.415%
Pacific Shuanglin Bio-pharmacy Co., LTD	612.11 Million CNY	83.186%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	43.93 Million CNY	-134.257%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.45 Billion CNY	92.95%
Chengdu Huasun Technology Group Inc., Ltd.	27.65 Million CNY	-272.089%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	138.37 Million CNY	25.623%
Hengkang Medical Group Co., Ltd.	30.77 Million CNY	-234.403%
Anhui Huangshan Capsule Co., Ltd.	64.86 Million CNY	-58.668%
Walvax Biotechnology Co., Ltd.	419.39 Million CNY	75.46%
Tianjin Ringpu Bio-Technology Co.,Ltd.	452.94 Million CNY	77.278%
Anhui Fengyuan Pharmaceutical Co., Ltd.	159.28 Million CNY	35.388%
Apeloa Pharmaceutical Co.,Ltd	1.05 Billion CNY	90.248%
Harbin Gloria Pharmaceuticals Co., Ltd	120.33 Million CNY	14.473%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	2.85 Billion CNY	96.393%
Hunan Hansen Pharmaceutical Co., Ltd.	205.01 Million CNY	49.8%
Xiamen Kingdomway Group Company	276.71 Million CNY	62.807%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	27.35 Million CNY	-276.172%
Zhuhai Rundu Pharmaceutical Co., Ltd.	66.89 Million CNY	-53.842%
Hainan Haiyao Co., Ltd.	-106.48 Million CNY	196.647%
Shenzhen Neptunus Bioengineering Co., Ltd.	-1.68 Billion CNY	106.09%
Fujian Cosunter Pharmaceutical Co., Ltd.	-348.58 Million CNY	129.524%
Huapont Life Sciences Co., Ltd.	302.12 Million CNY	65.935%
Livzon Pharmaceutical Group Inc.	1.95 Billion CNY	94.732%
Honz Pharmaceutical Co., Ltd.	11.52 Million CNY	-792.62%
Northeast Pharmaceutical Group Co., Ltd.	358.45 Million CNY	71.289%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	-783.25 Million CNY	113.14%
Hainan Poly Pharm. Co., Ltd	85.92 Million CNY	-19.779%
Sunflower Pharmaceutical Group Co.,Ltd	1.11 Billion CNY	90.804%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	618.89 Million CNY	83.371%
Kunming Longjin Pharmaceutical Co., Ltd.	-70.94 Million CNY	245.074%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-420.05 Million CNY	124.501%
Zhejiang Yatai Pharmaceutical Co., Ltd.	-11.87 Million CNY	966.533%
Zhejiang NHU Company Ltd.	2.7 Billion CNY	96.194%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	64.35 Million CNY	-59.918%
Jiuzhitang Co., Ltd.	297.41 Million CNY	65.395%
Qianjiang Yongan Pharmaceutical Co., Ltd.	-12.31 Million CNY	935.877%
Jinghua Pharmaceutical Group Co., Ltd.	247.69 Million CNY	58.45%
Hunan Er-Kang Pharmaceutical Co., Ltd	-195.32 Million CNY	152.691%
Yunnan Baiyao Group Co.,Ltd	4.09 Billion CNY	97.486%
ApicHope Pharmaceutical Co., Ltd	184.61 Million CNY	44.252%
Shandong Wohua Pharmaceutical Co., Ltd.	58.76 Million CNY	-75.128%
Jinling Pharmaceutical Company Limited	99.65 Million CNY	-3.277%
Beijing SL Pharmaceutical Co., Ltd.	416.69 Million CNY	75.301%
Shanxi Zhendong Pharmaceutical Co.,Ltd	-43.98 Million CNY	333.989%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	110.43 Million CNY	6.804%
Huaren Pharmaceutical Co., Ltd.	188.06 Million CNY	45.275%
Betta Pharmaceuticals Co., Ltd.	348.03 Million CNY	70.429%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	61.64 Million CNY	-66.945%
Changzhou Qianhong Biopharma CO.,LTD	181.86 Million CNY	43.408%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.04 Billion CNY	90.149%
Changjiang Pharmaceutical Group Co., Ltd.	-605.65 Million CNY	116.993%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	161.53 Million CNY	36.288%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	192.34 Million CNY	46.494%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	361.82 Million CNY	71.556%
Guangdong Lifestrong Pharmacy Co., Ltd.	33.5 Million CNY	-207.202%
Huadong Medicine Co., Ltd	2.83 Billion CNY	96.375%
PKU HealthCare Corp.,Ltd.	44.35 Million CNY	-132.024%
Hybio Pharmaceutical Co., Ltd.	-513.87 Million CNY	120.028%
Shenzhen Weiguang Biological Products Co., Ltd.	218.65 Million CNY	52.931%
Fuan Pharmaceutical (Group) Co., Ltd.	231.86 Million CNY	55.614%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.03 Billion CNY	90.075%
Harbin Medisan Pharmaceutical Co., Ltd.	73.66 Million CNY	-39.714%
Teyi Pharmaceutical Group Co.,Ltd	253.17 Million CNY	59.349%
Tus-Pharmaceutical Group Co., Ltd.	25.24 Million CNY	-307.647%
LanZhou Foci Pharmaceutical Co.,Ltd.	67.18 Million CNY	-53.175%
Changchun High-Tech Industries (Group) Inc.	4.53 Billion CNY	97.729%
Shanghai Kaibao Pharmaceutical CO.,Ltd	327.87 Million CNY	68.61%
Shandong Xinhua Pharmaceutical Company Limited	496.51 Million CNY	79.272%
Beijing Beilu Pharmaceutical Co., Ltd	-71.75 Million CNY	243.425%
Dezhan Healthcare Company Limited	83.31 Million CNY	-23.53%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	506.63 Million CNY	79.686%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-148.52 Million CNY	169.291%
Jinhe Biotechnology CO., LTD.	86.45 Million CNY	-19.039%
Baotou Dongbao Bio-Tech Co.,Ltd	119.88 Million CNY	14.153%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	25.19 Million CNY	-308.476%
Tibet AIM Pharm. Inc.	15.38 Million CNY	-568.885%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	263.27 Million CNY	60.908%
Nanjing Hicin Pharmaceutical Co., Ltd.	36.31 Million CNY	-183.399%
Renhe Pharmacy Co., Ltd.	567.25 Million CNY	81.857%
Wuhan Hiteck Biological Pharma Co.,Ltd	-120.82 Million CNY	185.181%
Guizhou Xinbang Pharmaceutical Co., Ltd.	287.23 Million CNY	64.169%
Dong-E-E-Jiao Co.,Ltd.	1.15 Billion CNY	91.057%
Jiangxi Synergy Pharmaceutical Co., Ltd.	105.98 Million CNY	2.892%
Chongqing Pharscin Pharmaceutical Co., Ltd.	32.69 Million CNY	-214.742%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	563.08 Million CNY	81.722%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-661.13 Million CNY	115.567%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-414.51 Million CNY	124.829%

Global Stocks Search

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)

Net Income Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Annual Net Income Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Net Income Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.